What must a Wegovy letter of medical necessity include?

A strong letter should include patient demographics, current BMI with measurement date, ICD-10 diagnosis code such as E66.01 or E66.9 with documented comorbidity, weight history, failed prior therapies with dates and outcomes, relevant comorbidities with lab values when available, clinical rationale for Wegovy specifically, and the prescriber NPI with signature. It should directly address the denial reason on your pharmacy notice, not only state that the patient needs the medication.

Can I write my own letter of medical necessity for Wegovy?

You can draft supporting materials, but insurers require a signed letter from a licensed prescriber. Patient-written letters alone are usually denied. Provide your doctor a bullet-point summary of failed therapies, comorbidities, and the specific denial code so they can write a targeted clinical letter.

How long should a Wegovy medical necessity letter be?

One to two pages is typical. Shorter than one page often lacks the clinical detail plans require. Longer than three pages can bury the key arguments. Focus on dated metrics, ICD-10 codes, and step therapy documentation rather than general statements about obesity.

Does my doctor submit the letter through CoverMyMeds or Express Scripts?

It depends on your PBM. Many prescribers submit initial prior auths through CoverMyMeds, but formal appeals after denial may require upload to Express Scripts, OptumRx, or Caremark member portals. Ask your doctor's office which portal they use and confirm the letter was attached before your appeal deadline.

What ICD-10 code should appear on a Wegovy medical necessity letter?

For chronic weight management, use E66.01 or E66.9 with documented comorbidities when BMI is below 30. Do not use E11.x diabetes codes unless your plan has a separate diabetes GLP-1 pathway. A code mismatch between the letter and the prior auth request is a frequent cause of automatic denial.

Can I reuse a medical necessity letter from a different GLP-1 medication?

No. Each drug has distinct FDA indication criteria. If you are switching from Saxenda to Wegovy or appealing a Wegovy-specific denial, the letter must cite Wegovy and explain why this formulation is clinically appropriate for your case.

What if my doctor refuses to write a detailed medical necessity letter?

Ask for a peer-to-peer review instead so your prescriber speaks directly with the insurer medical director. If your clinic lacks prior auth staff, bring a prepared clinical summary and use AppealFlow's GLP-1 generator to draft a formal appeal letter for your prescriber to review and sign.

How soon after a denial should the medical necessity letter be submitted?

As soon as possible. Many ERISA employer plans allow 180 days from the denial notice for an internal appeal, but waiting means more weeks without medication. Expedited appeals require the prescriber to certify that delay poses a serious health risk, which must appear in the letter itself.

Wegovy Medical Necessity Letter Sample

By AppealFlow editorial•11 min read•Published July 2026•Updated September 2026

A Wegovy medical necessity letter must be written and signed by your prescribing clinician, not copied from a template alone. It should include current BMI with measurement date, ICD-10 obesity codes, documented step therapy failures, and a direct response to your denial reason. Appeal deadlines vary by plan type, so confirm the date on your pharmacy denial letter or EOB before you submit through your PBM portal.

What Must a Wegovy Medical Necessity Letter Include?

Key Takeaway: Insurer medical directors approve letters with dated clinical metrics tied to plan criteria. Your prescriber must address the exact denial reason, cite FDA Wegovy indication criteria, and document every required step therapy with dates and outcomes.

Wegovy is FDA-approved for chronic weight management in adults with BMI at or above 30, or at or above 27 with a weight-related comorbidity. Plans may still require prior authorization and may exclude GLP-1 weight-loss drugs from the formulary. Your letter must map your records to the plan's pharmacy criteria, not just restate the FDA label.

Patient identifiers: full name, date of birth, member ID, and prescription date
Clinical measurements: height, weight, BMI with date of measurement
Diagnosis: ICD-10 E66.01 or E66.9 with documented comorbidities when BMI is below 30
Step therapy history: each required therapy with start and end dates, dose, duration, and outcome
Prescriber credentials: name, specialty, NPI, office address, phone, and signature

For the full appeal workflow after denial, see our guide on how to appeal a Wegovy denial.

How Do You Get Your Doctor to Write the Letter?

Key Takeaway: Do not wait for your doctor to initiate the letter. Bring a prepared clinical summary, your denial letter, and this template structure to your appointment or portal message.

Pull your denial letter and note the reason code on the pharmacy EOB.
Create a one-page clinical summary listing BMI history, comorbidities, and failed therapies.
Request the letter on letterhead with NPI and a direct response to the denial code.
Review the draft for matching dates, BMI, and ICD-10 codes before submission.
Submit through the PBM portal or fax path named on your denial notice.
Call member services to confirm the letter was received and linked to your appeal case.

Sample Wegovy Letter of Medical Necessity Template

Key Takeaway: Replace every bracketed placeholder with your actual clinical data. Your prescriber must review, modify as clinically appropriate, sign, and date the final version before you attach it to an appeal.

[Prescriber Name, MD/DO]

[Practice Name] | NPI: [NPI Number]

[Address] | [Phone]

[Date]

Re: Letter of Medical Necessity for Wegovy (semaglutide 2.4 mg)

Patient: [Full Name] | DOB: [Date] | Member ID: [ID]

I am writing to establish medical necessity for Wegovy (semaglutide 2.4 mg subcutaneous injection) for the above-named patient, who meets FDA-approved indication criteria for chronic weight management.

Diagnosis: Morbid obesity (ICD-10 E66.01). Current BMI: [XX.X] measured on [date]. Weight history: [starting weight] to [current weight] over [timeframe].

Weight-related comorbidities: [Hypertension I10, BP [value] on [date]; Prediabetes R73.03, HbA1c [value]% on [date]; Obstructive sleep apnea G47.33, diagnosed [date]].

Prior weight-loss interventions (step therapy):

Intensive lifestyle modification: [dates], outcome: [weight change or percent loss]
Metformin [dose]: [dates], discontinued due to [intolerance or insufficient response]
Phentermine [dose]: [dates], discontinued due to [tachycardia or insufficient response]

Clinical rationale: Patient has failed required step therapies per plan criteria. Wegovy is indicated for chronic weight management in adults with BMI at or above 30, or at or above 27 with a weight-related comorbidity.

This letter responds to denial code [code]. I respectfully request approval of Wegovy 2.4 mg with a [12-month] treatment duration. Please contact my office at [phone] for additional records.

Sincerely,

[Prescriber Signature]

[Prescriber Name, MD/DO] | NPI: [Number]

Weak vs. Strong Medical Necessity Language

Key Takeaway: Replace vague clinical statements with dated metrics, ICD-10 codes, and plan criteria references. Reviewers process many letters daily. Specificity is what separates a complete packet from one that bounces back.

❌ Weak Statement	✓ Strong Statement
“Patient is obese and would benefit from Wegovy.”	“Patient BMI 33.8, ICD-10 E66.01, measured 06/15/2026, with hypertension I10 and prediabetes R73.03. Meets FDA Wegovy criteria for BMI at or above 27 with weight-related comorbidity.”
“Patient tried diet and exercise without success.”	“Patient completed 6 months of registered dietitian-supervised program with documented weight loss of 3 lbs. Metformin 1000 mg BID for 90 days discontinued due to persistent nausea per visit note 05/12/2026.”
“Please approve Wegovy for this patient.”	“This letter addresses denial code [code]. All required step therapies per plan formulary Section [X] have been completed with documented failure. I request formulary exception and prior authorization approval for Wegovy 2.4 mg.”

Draft Your Wegovy Appeal Letter

AppealFlow's GLP-1 generator builds a regulation-informed letter from your denial reason and clinical facts. Edit live, then download PDF or Word before you upload to your PBM portal.

GLP-1 Appeal Generator

What Comorbidity Records Strengthen the Letter?

Key Takeaway: If your BMI is between 27 and 30, comorbidity documentation is mandatory under FDA labeling and most plan criteria. Insurers may deny without objective evidence of at least one weight-related condition beyond obesity itself.

Hypertension I10: two BP readings above 130/80 on separate dates
Prediabetes R73.03: HbA1c 5.7 to 6.4 percent or fasting glucose 100 to 125 mg/dL
OSA G47.33: sleep study results or CPAP prescription
Dyslipidemia E78.5: LDL above goal despite statin therapy

Attach lab results directly to the appeal packet. Do not rely on the letter alone to reference values your insurer cannot verify. For step therapy exceptions, see how to bypass step therapy for weight-loss medications.

How Do You Submit the Letter Through Your PBM?

Key Takeaway: The letter must be attached to a formal appeal, not only uploaded to an initial prior auth request. After denial, the appeal process has different submission channels than the first prior auth form.

Platform	Common plans	Letter submission
CoverMyMeds	Multiple PBMs	Provider uploads letter via key code; attach as appeal supporting doc
Express Scripts	Cigna and some BCBS plans	Member portal Pharmacy section or fax on denial letter
OptumRx	UnitedHealthcare and some employer plans	OptumRx.com prior authorization appeal workflow
Caremark	Aetna and CVS Health plans	Caremark.com Coverage and Claims appeal path

Appeal deadlines depend on plan type. Many ERISA employer plans allow 180 days from the denial notice for an internal appeal. ACA marketplace plans often use shorter windows printed on the notice. Confirm your date before you submit.

What Mistakes Invalidate Medical Necessity Letters?

Key Takeaway: A strong letter attached to a weak appeal process still fails. Avoid documentation errors that cause automatic denials regardless of clinical merit.

Missing NPI or signature. Unsigned letters are returned without review.
Outdated BMI. Weight measurements older than 90 days are frequently rejected.
Wrong ICD-10 code. E11.x diabetes codes on a weight management appeal can trigger automatic denial.
No response to denial reason. Generic letters that ignore the specific denial code get treated as new prior auth requests.
Submitting without the appeal form. The letter supports a formal appeal. It does not replace the filing itself.

Common mistake: Using a letter written for Ozempic for a Wegovy appeal. The FDA indications, doses, and ICD-10 codes differ. Your letter must reference Wegovy specifically.

Frequently Asked Questions

Common questions about Wegovy letters of medical necessity, prescriber requirements, and PBM submission.

Generate Your Free Wegovy Appeal Letter

AppealFlow drafts formal GLP-1 appeal letters citing FDA indication criteria and your specific denial reason. Edit the draft, then export PDF or Word. No account required.

GLP-1 Appeal Generator General Appeal Tool

100% Free
No Signup
PDF & Word Export

Disclaimer: This article is for educational purposes only and does not constitute medical or legal advice. AppealFlow.net is not a healthcare provider or law firm. Wegovy coverage rules, PBM portals, and appeal deadlines vary by plan and contract year. Verify requirements on your denial letter and formulary before filing. For medical emergencies, call 911. See our full disclaimer.